MDLN vs SRTA
MDLN: Medline is a leading global manufacturer and distributor of medical supplies and clinical solutions serving healthcare providers across the care continuum. SRTA: A time-critical logistics and clinical services provider offering integrated air/ground organ transport, surgical organ recovery, and cardiac perfusion solutions to the U.S. transplant ecosystem.
Side-by-side fundamentals
| Metric | MDLN | SRTA | Edge |
|---|---|---|---|
| Price as of 2026-08-05 close | $36.67 | $5.14 | |
| Market cap as of 2026-08-06 | $48.2B | $455M | |
| P/E as of 2026-08-06 | 49.86 | 10.90 | SRTA lower |
| PEG as of 2026-08-06 | 12.71 | n/a | |
| Net margin as of 2026-08-06 | +3.3% | +18.5% | SRTA higher |
| Gross margin as of 2026-08-06 | +25.9% | -39.7% | MDLN higher |
| Operating margin as of 2026-08-06 | +7.1% | -7.8% | MDLN higher |
| ROE as of 2026-08-06 | +6.9% | +17.5% | SRTA higher |
| ROA as of 2026-08-06 | +2.6% | +15.1% | SRTA higher |
| Debt / equity as of 2026-08-06 | 1.12 | 0.00 | SRTA lower |
| Revenue growth (YoY) as of 2026-08-06 | +10.7% | +19.6% | SRTA higher |
| Revenue CAGR (3y) SEC XBRL | +10.6% | +10.5% | MDLN higher |
| Beta as of 2026-08-06 | 1.16 | 2.46 | |
| 1-year return as of 2026-07-27 close | n/a | +19.5% |
Fundamentals: market data, as of 2026-08-06. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-05.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.